179
Participants
Start Date
November 20, 2018
Primary Completion Date
July 29, 2024
Study Completion Date
July 29, 2024
Firazyr
Participants with Hereditary angioedema (HAE) receiving treatment with Icatibant acetate (Firazyr) as prescribed by their physician following locally approved prescribing information.
Nagoya-city, Nagoya
Toyohashi-city, Toyohashi
Maebashi-city, Maebashi
Asahikawa-city, Asahikawa
Fukagawa-city, Fukagawa
Rumoi-city, Rumoi
Sapporo-city, Sapporo
Kasama-city, Kasama
Maizuru-city, Maizuru
Kishiwada-city, Kishiwada
Takatsuki-city, Takatsuki
Kawagoe-city, Kawagoe
Soka-city, Sōka
Numazu-city, Numazu
Shimada-city, Shimada
Yaezu-city, Yaezu
Tachikawa-city, Tachikawa
Niigata-city, Niigata